The future of nutrition is personal.

Built on biotic science. Guided by Ridli. Delivered daily.

$1.0MRaising
$300KClosed
$700KRemaining

Confidential · November 2026

The problem

Supplements are built for everyone.
That’s the problem.

In our view, one-size-fits-all formulas are why most people never feel a difference, and why they stop.

01

Same formula for every body

Generic stacks ignore goals, sensitivities, and routines.

02

No feedback loop

Nothing changes when life, training, or symptoms change.

03

No relationship after checkout

Brands sell a bottle, then disappear until the next ad.

Our answer

Most probiotics are made from dairy, soil, or animal strains. We start with Human Strain™: a clinically studied, human-origin Bifidobacterium adolescentis (B. adolescentis iVS-1®).

Investment case

One platform. Multiple sources of value.

R3VY is building a personalized nutrition platform that connects differentiated products, AI-guided relationships, and daily routines to create revenue for our brands and clients.

01 · Science

Biotic assets + strains

iVS-1® and KGA-10 create the starting point. Research informs the next candidates.

Shared foundation

R3VY AI platform

Evidence + agents + human review. Execution across the full cycle.

02 · Commercial execution

Products + relationships

Hero products lead to personalized routines, repeat purchases, and client services.

03 · Reusable learning

Prompts + execution traces

Evaluated workflows and permissioned records build reusable operating know-how.

Learning informs the next asset.

Every cycle strengthens execution.

New assets and services are a development thesis, not booked value. Prompt and trace value depends on rights, consent, evaluation, and reuse; no standalone valuation is assigned.

The wedge works

Holy Cow!™
I can digest dairy again.

“A bowl of cereal doesn’t result in anywhere near the reaction it used to.”

“I’ve noticed higher tolerance for milk and dairy than before.”

✓ Verified customer
From reactive enzyme tablets around dairy meals to one daily probiotic designed to rebuild confidence. A modern alternative to the meal-timed lactase-enzyme model introduced in the 1970s.
Holy Cow! once-daily lactose digestion support, 30 capsules

Holy Cow!™ is a once-daily probiotic for lactose digestion support with occasional dairy; it is not a lactase enzyme. Quotes are from verified customers and reflect individual experience.

Future cast · Product development

Holy Cow!™ can grow beyond one bottle.

Holy Cow! lineup: Jr Single Strain (LIVE Q4), Once Daily Lactose Digestion Support (LIVE 2026), Lactase Enzyme Gummies (2027), Sleep Gummies (2027), Once Daily Sleep & Stress Support capsules (longer-term R&D)R&D
Today

Once-daily lactose digestion support is the commercial starting point.

Next tests

Jr targets Q4 entry; a family bundle and optional enzyme gummies extend the routine.

Longer-term R&D

Develop once-daily sleep and stress support capsules alongside the planned 2027 gummy formats.

Illustrative packaging. LIVE 2026 / LIVE Q4 / 2027 reflect management timing; future formats remain subject to formulation, claims, and launch review. Pediatric suitability requires review. The current Holy Cow!™ capsule is a probiotic; Lactase Enzyme Gummies are a separate planned product.

Commercial proof

Customers love the products. Athletes put them to the test.

5,000+
Direct orders
$180
Customer LTV
+30%
Peak MoM growth
$7.21
Finished-unit cost
Kyan Olshove racing
Kyan Olshove2026 Iceman Cometh Pro Men’s ChampionElement community athlete
~$15
Customer CAC · approx. 12× LTV / CAC
84%
Retail product margin at $45 retail, before channel costs
4.8★
Average rating across all brands
85%
Customer retention (management estimate)
Go deeper
Upgrade paths: add Rhythm prebiotic, explore testing, or a personalized program.

Operating metrics are management reported. LTV is a company-reported estimate. Retention is a management estimate; cohort and period require reconciliation. Athlete experience is not proof of product efficacy or a guarantee of performance. Race result: 9&10 News, Nov. 9, 2026. Photo: Element Longevity.

The science moat · Biotic-to-venture platform

Gut and mind foundations. Personalized from there.

Gut foundation · Commercial lead
B. adolescentis iVS-1®

Once-daily lactose digestion support. The focused hero product behind Holy Cow!™ that opens the customer relationship.

Mind foundation · In development
NeuroAlly™ KGA-10

A postbiotic candidate for sleep, mood, and stress propositions, and the basis of our next-brand concept.

Broader brand pathways
Element LongevityHuman Strain
Ridli + personal contextGoals, preferences, and human guidance.
Build on the foundationEligible ingredients, routines, and personalized delivery.

Foundations describe the product strategy, not complete nutrition or treatment. KGA-10 remains subject to clinical, regulatory, IP, supply, and commercial diligence. Personalization and delivery extensions are proposed.

The platform

Meet Ridli.

An AI nutrition companion that turns a single product into a personal routine. Text-first, with human guidance when needed.

Element Longevity Base, clinically studied probiotic, 30 capsules
Element Longevity

Here’s your

Race Block Pack

Personalized by Ridli for Alex

  • Electrolytes (sodium)500 mg
  • Creatine Monohydrate5 g
  • Magnesium Glycinate200 mg
  • Omega-31 g
  • Vitamin D32,000 IU
  • Tart Cherry500 mg

Base 30-count probiotic + a monthly personalized sachet

01Text Ridli. Goals, routine, and how you feel.
02Get your monthly pack. Base, plus a sachet built for you.
03Check in. Feedback shapes next month’s sachet.
9:41●●●
RidliYour AI nutrition companion
SMS

I started with Holy Cow!™. What else can I build on?

Let’s look at your goals and current routine, then explore what may fit alongside your foundational product.

Next month’s pack

  • Base 30-count probiotic
  • Personalized monthly sachet

Reviewed with human guidance when needed.

Sleep’s been rough this week.

Noted. I’ll factor that into next month’s sachet and check in Friday.

Message Ridli

Illustrative conversation. Ridli is not a diagnostic service. Consumer concept available; management reports an existing code foundation, and production readiness requires validation.

The Ridli hub

One companion. Everything that shapes your nutrition.

Ridli pulls supplements, labs, wearable data, and daily check-ins into one ongoing relationship. It learns what works for each person and updates their sachet every month, so every new data source makes the pack more specific and the customer stickier.

Supplements

30-count bottle + monthly personalized sachet.

Lab Work

Blood work + microbiome testing.

HRV / Wearable Data

Recovery, strain, and readiness.

RidliYour AI nutrition companion
Live

100-mile race in 8 weeks. Sleep’s been rough. My gut tightens after hour four.

I’m on it. Here’s a stack built for this block — only what you need.

This month’s sachet

  • Gut support for long efforts
  • Nightly recovery support
  • Race-week fueling support

30-count bottle + monthly sachet. Ships to you.

Tonight: wind down earlier and cut caffeine after 2. I’ll check in tomorrow morning.

Message Ridli

Nutrition Coach

Fueling for your training block.

Sleep Coach

Wind-down and recovery habits.

Gut Health

Base, a clinically studied probiotic, plus gut check-ins.

More data in, better pack out. Each source sharpens next month’s sachet.
One relationship. Products and services under one companion.
Stickier customers. Each connection is built to raise retention and LTV.

Lab, wearable, and coaching integrations are in development. Illustrative conversation. Ridli is not a diagnostic service.

How it compounds

Start with a hero product. Build with Ridli.

01

Start with the hero

A focused gut or mind foundation customers can feel.

02

Ask for more

New goals and questions bring Ridli in.

03

Personalize

Eligible additions, chosen with guidance, in the monthly pack.

04

Check in

Feedback informs the next routine, and the next order.

Every check-in feeds the next month

For consumers

The hero product starts the relationship.

Customers start with a focused product, then ask for more. Ridli connects education, preferences, and check-ins to appropriate additions over time.

For practitioners

A private, practice-specific experience.

The proposed extension connects approved practice knowledge and permissioned client context, with practitioners reviewing recommendations.

Consumer concept available. Management reports an existing code foundation; production readiness and practitioner data isolation require validation. Ridli is not a diagnostic service.

Shared engine

Every launch makes the next one faster and smarter.

Shared system of recordR3VY AIAI agents orchestrate execution
Pro LLMFormulation agents preserve the thesis
02ScienceResearch agents connect evidence
Consumer LLMInsight agents surface human needs
04BrandCreative agents shape the promise
05ChannelsGrowth agents optimize conversion
06LearningLearning agents return outcomes
Focused venturesHoly Cow!™Great Brain DaySupporting venturesElement LongevityHuman Strain
Faster launchesAI agents reuse evidence, formulas, workflows, and company context.
Lower CACCreative and channel learning returns to the shared system of record.
Higher LTVCustomer history informs protocols, retention, and the next offer.
Better marginsUnit economics and supply decisions compound across the portfolio.

AI agent workflows describe the operating model and development thesis; outcomes are not booked value.

Personalization + fulfillment

A biotic foundation. A broader daily routine.

Invest in differentiated hero products. Use qualified dropship partners for traditional ingredients that complement the routine.

Foundation

Focused biotics

iVS-1® leads today. KGA-10 is a candidate for the next evidence-led proposition, subject to diligence.

→

Orchestration

Ridli+R3VY AI

Ridli + R3VY AI

Permissioned context, approved evidence, and human review inform eligible selections. MCP is the proposed tool-connection layer.

→

Asset-light expansion

Qualified partnersDropship

Dropship traditional ingredients

Qualified partners fulfill eligible complementary products. R3VY directs development capital toward more differentiated heroes, rather than owning every SKU.

Own the heroes. Expand the routine through partners.

Proposed architecture, not a verified live integration or a commitment to supply any ingredient. Safety, claims, data consent, catalog availability, and unit economics are launch gates.

Portfolio

Three existing brands. A next-brand opportunity.

Holy Cow!
Commercial lead

Holy Cow!™

Daily lactose digestion support, growing into a carefully tested family of formats.

Element Longevity Base, clinically studied probiotic, 30 capsules
Element Longevity

Here’s your

Race Block Pack

Personalized by Ridli for Alex

  • Electrolytes (sodium)500 mg
  • Creatine Monohydrate5 g
  • Magnesium Glycinate200 mg
  • Omega-31 g
  • Vitamin D32,000 IU
  • Tart Cherry500 mg
Active adults

Element Longevity

Biotic routines for training and everyday movement.

Ridli Coach “What are you training for? Let’s build your routine.”

B. longum
Synbiotic
Vitalis
Practitioner-first

Human Strain

Strain-specific nutrition for practices and clients.

Ridli Guide “Share your goals. Let’s prepare a plan with your practitioner.”

Great Brain Day is a concept subject to evidence, formulation, and launch review. Product images are illustrative packaging.

Go-to-market

Win the wedge. Scale discovery.

$10B+
Focused gut-health category
200M+
Broader health context
AI + short-form
Discovery and education
Holy Cow!
Short-form videoDTCAmazon
Holy Cow!™

A name built for short-form

A familiar expression and a ready-made creative hook. Creator clips drive discovery; DTC and Amazon handle purchase and replenishment.

Mountain biker on a forest trail
Element Longevity

Bike + run stores

Specialty-store pilots pair staff education, clubs, and coaches with QR-led AI onboarding.

Human Strain
Human Strain

Practices + practitioners

SMS-first intake, strain education, practitioner review, and private product ordering.

Creator content→Rights-cleared clips→Measured distribution→DTC / Amazon→Ridli-led relationships

Store pilots and practitioner access are proposed; AI and partner workflows are in development; placements and outcomes are not assumed.

Four-year financial path

From $204.5K to $18.43M in net revenue.

$204.5K
$2.75M
$7.38M
$18.43M
2026Net revenue
($151.6K) net income / (loss)
10 months actual + 2 forecast
2027Net revenue
($364.4K) net income / (loss)
Forecast
2028Net revenue
$1.07M net income / (loss)
Forecast
2029Net revenue
$6.32M net income / (loss)
Forecast
Nov 2027
First forecast profitable month
2028
First profitable full year
$6.32M
2029 forecast net income

Financial outlook figures are management projections and forward-looking statements, not guarantees. 2026 reflects 10 months of actuals plus 2 months forecast; 2027–2029 are forecasts.

Four-year outcome

Year 4 creates two credible paths to liquidity.

$5M
Executed SAFE valuation cap
$55–74M
Illustrative 2029 value
11–15×
Illustrative value-to-cap ratio
Path A

Sell the platform

A strategic acquirer buys the portfolio, differentiated strain access, clinical evidence, customer data, and AI operating system together.

Path B

Sell a breakout brand

A category winner such as Holy Cow!™ exits independently while R3VY keeps the engine, science base, and remaining portfolio upside.

Strategic buyers are paying for science, trust, and channel reach

GRÜNS
$1.2BReported EV
Unilever · 2026 · Fast-growing vitamins, minerals, and supplements brand
Thorne
$3.8BAnnounced
P&G · 2026 · Science-led platform after L Catterton’s 2023 take-private
Nutrafol
~$826MCash purchase, further 67%
Unilever · 2022 · Science-led hair wellness; 80% total ownership
Bountiful core brands
$5.75B3.1× net sales
Nestlé Health Science · 2021 · Nature’s Bounty, Solgar, Osteo Bi-Flex, Puritan’s Pride

The case is not size parity. It is buyer appetite for differentiated, science-led wellness brands with trusted channels.

2029 value and value-to-cap ratio are illustrative and forward-looking. GRÜNS and Thorne values were publicly reported; Unilever did not disclose the GRÜNS purchase price. Nutrafol reflects €811M converted at the ECB reference rate on July 7, 2022, for a further 67% (total ownership 80%). Bountiful from buyer disclosure.

Team

Three operators have already scaled brands and systems.

Haig Newton

Co-founder & CEO

Haig Newton

Scaled a health-and-wellness startup to $30M in annual revenue. Leads architecture, capital strategy, and AI-native systems.

Nick Perez

Co-founder & CMO

Nick Perez

Growth marketer who has scaled consumer brands to tens of millions in revenue. Leads positioning, acquisition, and growth.

Darren Becket

CXO

Darren Becket

Leads product strategy, scientific translation, supplier relationships, customer experience, and brand development.

Dr. Shekhar Challa

Dr. Shekhar Challa

Lead investor · Board-certified gastroenterologist

“Connecting the right science, ingredients, and products to specific human needs.”

The ask

Complete the $1M raise. Fund the next stage.

Retain the team. Protect inventory. Scale measured acquisition and develop the next heroes.

$1.0M
External target
$300K
Closed
$700K
Remaining

Closed: $200K direct equity + two $50K SAFEs. Separately, $116,167.96 in founder/partner capital brings total funding to $416,167.96.

$50K
Minimum · Post-money SAFE
$200K
Investment · Direct equity purchase

Use of funds · Prior six-month spending mix

34.4%TeamPayroll and people
25.5%Product + inventoryProduct costs and incremental inventory
25.9%Acquisition + channelsPaid media and marketplace / partner fees
14.2%Operations + AI / R&DOverhead, agent / compute, and Kioga development

Use-of-funds percentages reflect the prior six-month spending mix, shown as a guide to how capital is deployed; they are not a commitment for future allocation.

Thank you.

Let’s build the future of personal nutrition.

Built on biotic science. Guided by Ridli. Delivered daily.

Haig Newton

Co-founder & CEO · R3VY

haig@elementlongevity.com

Hero products.
Personal relationships.
One shared platform.

Confidential · Investor discussion · November 2026

Appendix

Notes & disclosures

Confidential. This presentation is for discussion with prospective investors only and is not an offer to sell or a solicitation of an offer to buy securities.

Operating metrics. Direct orders, LTV, CAC, LTV/CAC, peak MoM growth, finished-unit cost, retail product margin, rating, and retention are management reported. LTV is a company-reported estimate. Retention is a management estimate; cohort and period require reconciliation. Margin is at $45 retail before channel costs.

Forward-looking statements. The financial outlook (2026–2029), first profitable month and year, illustrative 2029 value, and value-to-cap ratio are projections and illustrations, not guarantees. 2026 reflects 10 months actual plus 2 months forecast.

Development thesis. New assets, brands, and services are a development thesis, not booked value. NeuroAlly™ KGA-10 remains subject to clinical, regulatory, IP, supply, and commercial diligence. Future formats and timing remain subject to formulation, claims, and launch review; pediatric suitability requires review.

Ridli. Ridli is not a diagnostic service. The consumer concept is available; management reports an existing code foundation, and production readiness and practitioner data isolation require validation. Conversations shown are illustrative.

Personalization and fulfillment. Partner fulfillment and tool-connection layers are proposed architecture, not a verified live integration or a commitment to supply any ingredient. Safety, claims, data consent, catalog availability, and unit economics are launch gates. Prompt and trace value depends on rights, consent, evaluation, and reuse; no standalone valuation is assigned.

Products. Holy Cow!™ is a probiotic, not a lactase enzyme. Customer quotes reflect individual experience. Packaging shown may be illustrative.

Athlete. Athlete experience is not proof of product efficacy or a guarantee of performance. Race result: 9&10 News, Nov. 9, 2026. Photo: Element Longevity.

Comparable transactions. GRÜNS and Thorne values were publicly reported; Unilever did not disclose the GRÜNS purchase price. Nutrafol reflects €811M converted at the ECB reference rate on July 7, 2022; Unilever bought a further 67%, bringing total ownership to 80%. Bountiful comes from buyer disclosure. The valuation case is not size parity.

Use of funds. Percentages reflect the prior six-month spending mix.

© 2026 R3VY. All rights reserved.

01 / 20